|
by La Fleur, Philip, Argáez, Charlene
Published 2017
“..., leukocyte content, red blood cell content, and the method of exogenous activation of platelets (e.g...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by La Fleur, Philip, Argáez, Charlene
Published 2017
“..., leukocyte content, red blood cell content, and the method of exogenous activation of platelets (e.g...”Published 2017
Canadian Agency for Drugs and Technologies in Health